HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 23002992, compound → 7-Chloro-8-morpholin-4-yl-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepine monohydrobromide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 23002992 | HCID 23002992 | — |
| Reactant | tert-butyl 7-chloro-8-morpholin-4-yl-2,3-dihydropyrido[3,2-f][1,4]oxazepine-4(5H)-carboxylate | HCID 67279788 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | 7-Chloro-8-morpholin-4-yl-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepine monohydrobromide | HCID 67280228 | 25% |
Reaction Steps
To a solution of the compound (0.10 g) obtained in step 1 in ethanol (1 mL) was added hydrobromic acid-ethanol solution (1 mL), and the mixture was stirred at room temperature for 4 hr. The solvent was evaporated under reduced pressure, and the aqueous layer was made basic with ethyl acetate and aqueous sodium hydroxide solution. The organic layer was washed with brine and dried, and the solvent was evaporated under reduced pressure. Ethyl acetate was added to the residue, and hydrobromic acid-ethanol solution was added. The precipitate was collected by filtration to give the title compound (0.03 g, 25%) as a white powder.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08158617B2 |
| Source dataset | uspto-grants-2012_04 |
| ORD ID | ord-46e55518a98a4a57b21a3df181202d8b |
| Source note | uspto-grants-2012_04 |